sur Biophytis (EPA:ALBPS)
Biophytis to Engage in Major Healthcare and Investment Events
Biophytis SA, a leader in developing therapies for longevity, is set to participate in two significant industry events this January 2026. The company will first attend the 44th JP Morgan Healthcare Conference in San Francisco, from January 12 to 15. This event is renowned as the largest global healthcare investment forum, featuring key figures from the pharmaceutical, biotechnology, and medical technology sectors alongside international investors.
Additionally, Biophytis will join the Biomed Forum organized by All Invest Securities in Paris on January 29. This gathering unites biotech and medtech enterprises with French and European institutional investors focused on healthcare. At these events, Biophytis plans to update attendees on their latest operational and clinical developments, as well as their strategic outlook for 2026.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Biophytis